EyePoint, Inc.
EYPTNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $271.75M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.93$19.11
- Volume (live)
- -
- Avg. volume (3M)
- 3.20M
EyePoint (EYPT) Stock Price & Financial Analysis
EyePoint Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.01 - $3.18 |
|---|---|
| 52-Week High | $19.11 |
| 52-Week Low | $2.93 |
| Open | $3.02 |
| Volume (last close) | 2.84M |
| Average Volume (3M) | 3.20M |
| Revenue (TTM) | 2.79M |
|---|---|
| Net Income (TTM) | -306.64M |
| Free Cash Flow (TTM) | -271.28M |
| EPS (TTM) | −$3.77 |
| Profit Margin | -10994.73% |
| Operating Margin | -11365.22% |
| Return on Equity (ROE) | -184.27% |
| Debt to Equity | 0.13 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 271.75M |
|---|---|
| Shares Outstanding | 86.54M |
| Price to Sales (P/S) | 97.43 |
| Price to Book (P/B) | 1.63 |
| EV/EBITDA | -0.62 |
| 50-Day MA | $5.58 |
|---|---|
| 200-Day MA | $11.96 |
| 1-Year Change | −72.81% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
EyePoint at a Glance
As of the Oct 15, 2026 close, EyePoint (EYPT) has a market capitalization of $271.75M. The stock trades at 97.4× sales. Over the trailing twelve months it lost $306.64M on revenue of $2.79M and burned $271.28M of free cash flow. Revenue fell 94.6% year over year.
As of its latest reported balance sheet, it holds $110.46M in cash and securities against $22.37M of debt, a net cash position of $88.09M.
EyePoint does not currently pay a dividend.
The share price is down 72.8% over the past year. At $3.14 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $2.93 to $19.11, below its 200-day moving average of $11.96.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $18.25, 481.2% above the Oct 15, 2026 close.
Frequently Asked Questions About EyePoint
What is the current stock price for EYPT?
As of the Oct 15, 2026 close, EYPT stock trades at $3.14. The 52-week range is $2.93–$19.11, with a day range of $3.01–$3.17.
What is the P/E ratio for EYPT?
The P/E ratio (Price-to-Earnings) for EYPT is shown in the Key Statistics section. This valuation metric helps compare EyePoint, Inc. to industry peers.
Does EYPT pay dividends?
EyePoint does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EYPT?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for EYPT is Buy. The average 12-month price target is $18.25, a 481.2% upside from the Oct 15, 2026 close of $3.14.
What is the market cap of EYPT?
As of the Oct 15, 2026 close, EyePoint's market capitalization is $271.7M, classifying it as a micro-cap company. EyePoint operates in the Healthcare sector within the Biotechnology industry.